BioTie Therapies Oyj | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
336,430.00
401,480.00
492,660.00
519,601.00
588,287.00
Cost of Goods Sold (COGS) incl. D&A
66,643.00
80,615.00
92,931.00
108,109.00
135,714.00
Gross Income
269,787.00
320,865.00
399,729.00
411,492.00
452,573.00
SG&A Expense
238,573.00
268,466.00
354,839.00
421,274.00
343,012.00
EBIT
31,214.00
52,399.00
44,890.00
9,782.00
109,561.00
Unusual Expense
1,031.00
16,155.00
10,900.00
26,200.00
345,909.00
Non Operating Income/Expense
182.00
379.00
411.00
9,902.00
2,991.00
Interest Expense
2,170.00
9,288.00
15,472.00
16,527.00
18,664.00
Pretax Income
28,863.00
28,009.00
19,369.00
42,268.00
251,885.00
Income Tax
12,422.00
10,337.00
8,311.00
6,665.00
28,526.00
Consolidated Net Income
16,441.00
17,672.00
11,058.00
35,603.00
223,359.00
Net Income
16,441.00
17,672.00
11,058.00
34,618.00
223,359.00
Net Income After Extraordinaries
16,441.00
17,672.00
11,058.00
34,618.00
223,359.00
Net Income Available to Common
16,441.00
17,672.00
11,058.00
34,618.00
223,359.00
EPS (Basic)
0.39
0.42
0.25
0.76
4.86
Basic Shares Outstanding
40,208.00
41,150.00
42,230.00
45,259.00
45,999.00
EPS (Diluted)
0.39
0.42
0.25
0.76
4.86
Diluted Shares Outstanding
41,682.00
42,544.00
43,621.00
45,259.00
45,999.00
EBITDA
38,213.00
60,872.00
59,902.00
11,800.00
145,661.00
Non-Operating Interest Income
668.00
674.00
440.00
339.00
136.00
Minority Interest Expense
-
-
-
985.00
-
About BioTie Therapies Oyj
View Profile
